Novartis Ag NVS
NYSE NVS
$150.15 -0.47 (-0.31%)
As of: Oct 19, 2026 · 3:59 PM EDT

Novartis Ag (NVS) Restructuring Costs (2009 - 2018)

Updated

Novartis Ag (NVS) reported Restructuring Costs of $544 million for Q4 2025, up 11.7% from $487 million a year earlier.

Analysis

Novartis Ag (NVS) Restructuring Costs (2009 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 Vertex Pharmaceuticals 127.25 Bn 99.26 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -41.00 Mn
Dec 31, 2017 -30.00 Mn
Dec 31, 2016 -29.00 Mn
Dec 31, 2013 -65.00 Mn
Dec 31, 2012 -34.00 Mn
Dec 31, 2011 -192.00 Mn
Dec 31, 2010 -158.00 Mn
Dec 31, 2009 -40.00 Mn
API Access

Novartis Ag Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=NVS&period=max&api_key=YOUR_API_KEY